SOUTH CHINA VENTURE CAPITAL
South China Venture Capital is a private equity investment fund management as the main business of professional investment management organization. Under the jurisdiction of the three branch of the fund management company: Shenzhen South China Invsetment Management Co.Ltd, South China (Tianjin) Equity Investment Fund Management Co. Ltd., Shenzhen Zhongnan Hongyuan Invsetment Management Co. Ltd.
SOUTH CHINA VENTURE CAPITAL
Industry:
Finance Financial Services
Founded:
2008-03-01
Status:
Active
Contact:
0755-82520688
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Nginx DigiCert SSL
Similar Organizations
ANTS Capital
ANTS Capital is a private equity fund management firm.
Bridges Israel
Bridges Israel is an impact investment fund.
Canton Venture Capital
Canton Venture Capital is an equity investment management firm.
Pusu Capital
Pusu Capital is a private investment fund manager.
Yunshi Capital
Yunshi Capital is a private equity investment fund management organization.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-21 | Liufang Technology | South China Venture Capital investment in Series A - Liufang Technology | N/A |
| 2022-05-15 | Immunowake | South China Venture Capital investment in Series A - Immunowake | 20 M USD |
| 2022-03-04 | Wuxi Xinxiang | South China Venture Capital investment in Series A - Wuxi Xinxiang | 100 M CNY |
| 2022-01-04 | Accro Bioscience | South China Venture Capital investment in Series B - Accro Bioscience | 50 M USD |
| 2021-12-06 | Innoforce Pharmaceuticals | South China Venture Capital investment in Series A - Innoforce Pharmaceuticals | 375 M CNY |
| 2021-06-01 | Inmagene Biopharmaceuticals | South China Venture Capital investment in Series C - Inmagene Biopharmaceuticals | 100 M USD |
| 2021-03-22 | Innoforce Pharmaceuticals | South China Venture Capital investment in Series A - Innoforce Pharmaceuticals | 625 M CNY |
| 2021-02-25 | Cullgen | South China Venture Capital investment in Series B - Cullgen | 50 M USD |
| 2021-02-09 | Drug Farm | South China Venture Capital investment in Series A - Drug Farm | 56 M USD |
| 2020-11-08 | Inmagene Biopharmaceuticals | South China Venture Capital investment in Series B - Inmagene Biopharmaceuticals | 21 M USD |